Skip to main navigation Skip to search Skip to main content

Hormone profiling in a novel enteroendocrine cell line pGIP/neo: STC-1

Research output: Contribution to journalArticlepeer-review

Abstract

GIP is a peptide hormone of therapeutic interest in type 2 diabetes and obesity. This study evaluated pGIP/neo STC-1 as a potential K-cell model for studying GIP secretion.
Original languageEnglish
Pages (from-to)1683-6
Number of pages4
JournalMetabolism
Volume61
Issue number12
DOIs
Publication statusPublished - Dec 2012

Bibliographical note

Copyright © 2012 Elsevier Inc. All rights reserved.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Fingerprint

Dive into the research topics of 'Hormone profiling in a novel enteroendocrine cell line pGIP/neo: STC-1'. Together they form a unique fingerprint.

Cite this